Efficacy and Safety of AngongNiuhuang Pill in Patients With Acute Ischemic Stroke (ANGONG TRIAL)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

Also called NCT04475328

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04475328
Other papers using this trial's data
  • Safety and efficacy of Angong Niuhuang Pills in patients with moderate-to-severe acute ischemic stroke (ANGONG TRIAL): A randomized double-blind placebo-controlled pilot clinical trial Chinese medical journal, 2025-03-05 DOI, PubMed 39501831, PMC11882298 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04475328. Randomized; double masking; primary purpose treatment. Start 2020-10-01 (actual); primary completion 2022-05-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of AngongNiuhuang Pill in Patients With Acute Ischemic Stroke (ANGONG TRIAL)
Condition
Acute Ischemic Stroke
Intervention (Drug)
AngongNiuhuang pill
Intervention (Drug)
Placebo of AngongNiuhuang pill
Intervention (Other)
Standard treatment
Lead sponsor
Peking Union Medical College Hospital (class: other)

Record details

Record id
cardio:ct-nct04475328
Content hash
43ab202cebb0ef3cb2863695fca1994ca5a8f8da752837a4ba704a3f48cf2e61